Epistemic AI
Epistemic AI is a company dedicated to transforming biomedical research through advanced AI-powered knowledge discovery platforms. Their mission is to accelerate scientific discovery, improve research efficiency, and democratize access to complex biomedical data. They develop innovative tools such as Knowledge Maps and Biomedical GPT, which enable researchers to explore complex data, uncover hidden connections, and generate new hypotheses across disciplines in the life sciences. The company also focuses on drug discovery, development, and commercialization efforts, providing a comprehensive platform that supports hypothesis generation, literature review, target identification, drug repurposing, and competitive intelligence. Their work is supported by a team of software developers, AI scientists, biomedical scientists, and business professionals, as well as a network of investors and advisors.
Industries
Nr. of Employees
small (1-50)
Products
Knowledge Map workspace (interactive visualization)
Generates interactive visual maps of relationships among biomedical entities and supports iterative exploration, filtering, and evidence linking for exploratory research and hypothesis building.
Generative research assistant (conversational interface)
Conversational interface that answers biomedical queries using the underlying knowledge graph and links outputs to primary evidence for interactive, human-in-the-loop research workflows.
Drug Map (drug-target-indication analytics)
Connects drugs and chemicals to targets and indications with integrated data on trials, bioavailability, SAR and pharmacology to support target identification, drug repurposing, and PK/PD-informed analyses.
Trials Map (clinical trials analytics)
Extracts and aggregates clinical trial endpoints, outcomes, recruitment, and safety metadata to support outcome measurement, recruitment assessment, and comparative pipeline mapping.
Omics Analysis module
Performs gene enrichment, pathway identification, and variant analysis across multiple databases with species-specific context to inform biomarker selection and clinical interpretation.
PhenoMap / thematic extraction
Extracts high-frequency themes and common associations across selected publication cohorts to reveal recurring gene, pathway, drug, and disease associations for hypothesis generation.
Knowledge Map workspace (interactive visualization)
Generates interactive visual maps of relationships among biomedical entities and supports iterative exploration, filtering, and evidence linking for exploratory research and hypothesis building.
Generative research assistant (conversational interface)
Conversational interface that answers biomedical queries using the underlying knowledge graph and links outputs to primary evidence for interactive, human-in-the-loop research workflows.
Drug Map (drug-target-indication analytics)
Connects drugs and chemicals to targets and indications with integrated data on trials, bioavailability, SAR and pharmacology to support target identification, drug repurposing, and PK/PD-informed analyses.
Trials Map (clinical trials analytics)
Extracts and aggregates clinical trial endpoints, outcomes, recruitment, and safety metadata to support outcome measurement, recruitment assessment, and comparative pipeline mapping.
Omics Analysis module
Performs gene enrichment, pathway identification, and variant analysis across multiple databases with species-specific context to inform biomarker selection and clinical interpretation.
PhenoMap / thematic extraction
Extracts high-frequency themes and common associations across selected publication cohorts to reveal recurring gene, pathway, drug, and disease associations for hypothesis generation.
Services
Web-based access to the knowledge discovery platform for accredited academic researchers, including map creation, literature and trial search, and sharing tools.
Centralized, per-user licensing and administrative controls for academic labs and departments with shared resources and collaborative features.
Annual subscription and institution-level deployment for commercial R&D, competitive intelligence, and translational teams, including integration support and priority service.
Tailored integration of client datasets, custom curation, and bespoke map-building services to align the platform output with specific drug discovery or competitive intelligence workflows.
Web-based access to the knowledge discovery platform for accredited academic researchers, including map creation, literature and trial search, and sharing tools.
Centralized, per-user licensing and administrative controls for academic labs and departments with shared resources and collaborative features.
Annual subscription and institution-level deployment for commercial R&D, competitive intelligence, and translational teams, including integration support and priority service.
Tailored integration of client datasets, custom curation, and bespoke map-building services to align the platform output with specific drug discovery or competitive intelligence workflows.
Expertise Areas
- Knowledge graph–based biomedical discovery
- Literature and clinical-trial mining
- Clinical trial mapping and monitoring
- In-silico target identification and drug repurposing
Key Technologies
- Knowledge graphs
- Large language models and generative AI
- Natural language processing (NLP)
- Machine learning for information extraction
News & Updates
Epistemic AI announced the launch of its advanced Biomedical GPT platform at the BIO International Convention, aimed at providing immediate access to complex biomedical data.
The Cold Spring Harbor Laboratory has licensed Epistemic AI's platform to enhance their cystic fibrosis and respiratory disease research.
Partnerships with Leading Research Institutions
Epistemic AI has partnered with institutions like Dartmouth, Cincinnati Children’s, and CSHL to accelerate CF research and drug discovery.
Development of Next-generation AI Tools
Launch of Biomedical GPT and advanced knowledge maps to aid biomedical research and discovery.
Epistemic AI announced the launch of its advanced Biomedical GPT platform at the BIO International Convention, aimed at providing immediate access to complex biomedical data.
The Cold Spring Harbor Laboratory has licensed Epistemic AI's platform to enhance their cystic fibrosis and respiratory disease research.
Partnerships with Leading Research Institutions
Epistemic AI has partnered with institutions like Dartmouth, Cincinnati Children’s, and CSHL to accelerate CF research and drug discovery.
Development of Next-generation AI Tools
Launch of Biomedical GPT and advanced knowledge maps to aid biomedical research and discovery.